Press Release Archive
2007 | 2006 | 2005 | 2004 | 2003 | 2002
Memory Pharmaceuticals Announces Agreement with The Stanley Medical Research Institute for the Development of MEM 1003 for Bipolar Disorder
Memory Pharmaceuticals Corp. Press Release
December 20, 2005
Memory Pharmaceuticals Announces Preliminary Results from Safety and Tolerability Study for MEM 1003 in Alzheimer's Patients
Memory Pharmaceuticals Corp. Press Release
December 20, 2005
Memory Pharmaceuticals Reports Third Quarter 2005 Financial Results
Memory Pharmaceuticals Corp. Press Release
November 8, 2005
Memory Pharmaceuticals Commences Phase 2a Trial of MEM 1003 in Alzheimer's Disease
Memory Pharmaceuticals Corp. Press Release
November 4, 2005
Memory Pharmaceuticals to Announce Third Quarter 2005 Results on Tuesday, November 8, 2005
Memory Pharmaceuticals Corp. Press Release
November 1, 2005
Memory Pharmaceuticals Announces Collaboration to Develop PDE10 Inhibitors for Central Nervous System Disorders with Amgen
Memory Pharmaceuticals Corp. Press Release
October 17, 2005
Memory Pharmaceuticals to Present at BIO InvestorForum 2005
Memory Pharmaceuticals Corp. Press Release
October 12, 2005
Memory Pharmaceuticals Highlights Development Programs at the GTCBio Annual Conference on Therapeutic Strategies Against Neurodegenerative Conditions
Memory Pharmaceuticals Corp. Press Release
October 10, 2005
Memory Pharmaceuticals Completes Safety and Tolerability Study of MEM 1003
Memory Pharmaceuticals Corp. Press Release
September 26, 2005
Memory Pharmaceuticals Announces $31 Million Financing
Memory Pharmaceuticals Corp. Press Release
September 21, 2005
Memory Pharmaceuticals to Present at UBS Global Life Sciences Conference
Memory Pharmaceuticals Corp. Press Release
September 19, 2005
Memory Pharmaceuticals Amends PDE4 Collaboration with Roche
Memory Pharmaceuticals Corp. Press Release
August 18, 2005
Memory Pharmaceuticals Reports Second Quarter 2005 Financial Results
Memory Pharmaceuticals Corp. Press Release
August 9, 2005
Memory Pharmaceuticals to Announce Second Quarter 2005 Results on August 9, 2005
Memory Pharmaceuticals Corp. Press Release
August 3, 2005
Memory Pharmaceuticals to Present at the Banc of America Securities 2005 Health Care Conference
Memory Pharmaceuticals Corp. Press Release
May 12, 2005
Memory Pharmaceuticals Reports First Quarter 2005 Financial Results
Memory Pharmaceuticals Corp. Press Release
May 10, 2005
Memory Pharmaceuticals Appoints Tony Scullion as Executive Chairman and James R. Sulat as President and CEO
Memory Pharmaceuticals Corp. Press Release
May 10, 2005
Memory Pharmaceuticals to Announce First Quarter 2005 Results on Tuesday, May 10, 2005
Memory Pharmaceuticals Corp. Press Release
May 5, 2005
Roche Makes Initial Payment of $2 Million to Retain Option to License Memory Pharmaceuticals' MEM 3454
Memory Pharmaceuticals Corp. Press Release
May 3, 2005
Memory Pharmaceuticals to Present at the 5th Annual Fortis Bank Biotechnology Conference
Memory Pharmaceuticals Corp. Press Release
April 26, 2005
Memory Pharmaceuticals Provides Update on PDE4 Collaboration with Roche
Memory Pharmaceuticals Corp. Press Release
April 15, 2005
Memory Pharmaceuticals Provides Clinical Update on MEM 1003
Memory Pharmaceuticals Corp. Press Release
April 12, 2005
Memory Pharmaceuticals Nominates New Drug Candidate MEM 63908
Memory Pharmaceuticals Corp. Press Release
March 31, 2005
Memory Pharmaceuticals Announces Departure of Dr. Axel Unterbeck
Memory Pharmaceuticals Corp. Press Release
March 15, 2005
Memory Pharmaceuticals to Present at SG Cowen Health Care Conference
Memory Pharmaceuticals Corp. Press Release
March 10, 2005
Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2004 Financial Results
Memory Pharmaceuticals Corp. Press Release
February 25, 2005
Memory Pharmaceuticals Commences Phase I Study of MEM 3454
Memory Pharmaceuticals Corp. Press Release
February 25, 2005
Memory Pharmaceuticals Announces New Addition to Pipeline: PDE10A Inhibitor Program
Memory Pharmaceuticals Corp. Press Release
February 23, 2005
Memory Pharmaceuticals to Participate in Alzheimer's and Parkinson's Disease Panel at BIO CEO Conference
Memory Pharmaceuticals Corp. Press Release
February 18, 2005
Memory Pharmaceuticals Revises Date to Report Fourth Quarter and Year End 2004 Results
Memory Pharmaceuticals Corp. Press Release
February 17, 2005
Memory Pharmaceuticals to Announce Fourth Quarter and Year-End 2004 Results on Tuesday, February 22, 2005
Memory Pharmaceuticals Corp. Press Release
February 15, 2005
Memory Pharmaceuticals to Participate in the World Economic Forum Annual Meeting
Memory Pharmaceuticals Corp. Press Release
January 26, 2005
Tony Scullion Appointed to Board of Directors of the Biotechnology Council of New Jersey
Memory Pharmaceuticals Corp. Press Release
January 21, 2005
Alzheimer's Patients Dosed in Memory Pharmaceuticals' Safety & Tolerability Clinical Study of MEM 1003 in U.S.
Memory Pharmaceuticals Corp. Press Release
January 12, 2005